Lymphocyte infiltration in breast cancer: a key prognostic factor that should not be ignored

Editorial

Roger Mouawad et al. J Clin Oncol. 2011.

. 2011 May 20;29(15):1935-6.

doi: 10.1200/JCO.2011.35.4845. Epub 2011 Apr 11.

Retraction in

Retraction. Lymphocyte infiltration in breast cancer: a key prognostic factor that should not be ignored.
[No authors listed] [No authors listed] J Clin Oncol. 2011 Nov 20;29(33):4471. J Clin Oncol. 2011. PMID: 22204025 No abstract available.

No abstract available

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.
Denkert C, Loibl S, Noske A, Roller M, Müller BM, Komor M, Budczies J, Darb-Esfahani S, Kronenwett R, Hanusch C, von Törne C, Weichert W, Engels K, Solbach C, Schrader I, Dietel M, von Minckwitz G. Denkert C, et al. J Clin Oncol. 2010 Jan 1;28(1):105-13. doi: 10.1200/JCO.2009.23.7370. Epub 2009 Nov 16. J Clin Oncol. 2010. PMID: 19917869 Clinical Trial.
Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.
Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AH, Ellis IO, Green AR. Mahmoud SM, et al. J Clin Oncol. 2011 May 20;29(15):1949-55. doi: 10.1200/JCO.2010.30.5037. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21483002